Steven M. Fruchtman - 02 Aug 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role: PRESIDENT, CHIEF EXECUTIVE OFF, Director
Signature: /s/ Mark Guerin, Attorney-in-Fact
Issuer symbol: TRAW
Transactions as of: 02 Aug 2023
Net transactions value: -$4,791
Form type: 4
Filing time: 04 Aug 2023, 16:42:50 UTC
Previous filing: 14 Mar 2023
Next filing: 09 Feb 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONTX	Common Stock	Options Exercise		+12,567	+31%		53,044	02 Aug 2023	Direct	F1
transaction	ONTX	Common Stock	Tax liability	$4,791	-4,744	-8.9%	$1.01	48,300	03 Aug 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ONTX	Restricted Stock Units	Options Exercise	$0	-12,567	-50%	$0.000000	12,567	02 Aug 2023	Common Stock	12,567		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	On August 2, 2021 the reporting person was granted 37,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.